Expression and Localization of CLC Chloride Transport Proteins in the Avian Retina by McMains, Emily et al.
Expression and Localization of CLC Chloride Transport
Proteins in the Avian Retina
Emily McMains, Vijai Krishnan, Sujitha Prasad, Evanna Gleason*
Department of Biological Sciences, Louisiana State University, Baton Rouge, Louisiana, United States of America
Abstract
Members of the ubiquitously expressed CLC protein family of chloride channels and transporters play important roles in
regulating cellular chloride and pH. The CLCs that function as Cl
2/H
+ antiporters, ClCs 3–7, are essential in particular for the
acidification of endosomal compartments and protein degradation. These proteins are broadly expressed in the nervous
system, and mutations that disrupt their expression are responsible for several human genetic diseases. Furthermore, knock-
out of ClC3 and ClC7 in the mouse result in the degeneration of the hippocampus and the retina. Despite this evidence of
their importance in retinal function, the expression patterns of different CLC transporters in different retinal cell types are as
yet undescribed. Previous work in our lab has shown that in chicken amacrine cells, internal Cl
2 can be dynamic. To
determine whether CLCs have the potential to participate, we used PCR and immunohistochemical techniques to examine
CLC transporter expression in the chicken retina. We observed a high level of variation in the retinal expression levels and
patterns among the different CLC proteins examined. These findings, which represent the first systematic investigation of
CLC transporter expression in the retina, support diverse functions for the different CLCs in this tissue.
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Introduction
The distribution of Cl
2 across the plasma membrane is known
to be tightly regulated, primarily by the activity of two Cl
2 co-
transport proteins: the potassium/chloride co-transporter (KCC)
and the sodium/potassium/chloride co-transporter (NKCC).
These transport proteins are known to play a critical role in
setting the equilibrium potential for Cl
2 by adjusting cytosolic Cl
2
concentrations and thus determining the sign (inhibitory or
excitatory) of synaptic transmission mediated by GABA- or
glycine-gated Cl
2 channels. Another group of Cl
2 transporters,
the CLC transporters, also move Cl
2 across cellular membranes.
A subset of these transporters (ClCs 3–7) are chiefly expressed on
intracellular membranes (for review, see [1]). The activity of these
transporters also has the potential to affect Cl
2 distribution and
may prove to be another important factor contributing to the
dynamic nature of cytosolic Cl
2 concentration [2].
The vesicular CLCs can be subdivided into two groups based on
sequence similarity: ClCs 3, 4, 5 and ClCs 6, 7. Over the last
several years, biophysical studies of these transporters have
established that ClCs 3–7 are all Cl
2/H
+ antiporters
[3,4,5,6,7,8]. Furthermore, it has been established for ClC 4, 5
and 7 that the stoichiometry of exchange is 2Cl
2:1H
+ [3,4,5].
Additionally, CLCs are thought to operate as dimers with both
homo- and heterodimers observed in expression systems [9,10].
While the biophysical properties of the vesicular CLCs are
becoming clear, the functions of these transporters are less well
understood. Endosomal compartments are typically acidic due to
the presence of the V-type proton pump. This acidic environment
can facilitate other transport mechanisms and provide optimal
conditions for some enzyme functions. One proposed role for the
internal CLCs is that they move Cl
2 into endosomes as a counter
ion to relieve the steep membrane potential generated by the
proton pumping [11]. The cost of this CLC-dependent Cl
2
transport, however, is the exchange for protons previously moved
into the compartment by the ATP-dependent proton pump. The
resolution of this dilemma may be emerging from recent studies
utilizing mutations that convert ClCs 5 and 7 from Cl
2/H
+
antiporters into pure Cl
2 conductors [12,13]. The results of these
studies imply that the primary function of some CLCs may be to
concentrate Cl
2 in endosomal compartments. Another recent
study provides evidence that ClC5 plays a direct role in endosomal
acidification itself [2]. Thus the roles of the internal CLCs are just
coming into focus and it is possible that their functions are diverse
and may be dependent upon the specific cellular context in which
they reside.
The expression of ClCs 3–7 varies among cell types, however,
expression has been demonstrated for each of these transporters in
neuronal tissues [14,15,16,17,18]. Within cells, however, their
distribution differs with respect to their position in the endosomal
pathway. ClC3 resides in mid to late endosomes and synaptic
vesicles [19]. The localization of ClC4 is not completely resolved
but it seems to be in endosomal rather than lysosomal
compartments [1]. ClC5 is typically found in early endosomes
[20], and ClCs 6 and 7 in late endosomes and lysosomes [15,17].
Knockout studies and mutational analyses have shed light on some
of the physiological consequences of impaired CLC function.
ClC5 is mutated in the human kidney disorder Dent’s disease [21],
and ClC5 knockouts display impairments in the endocytic
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lysosomal storage disease in the central nervous system and in
the kidney [15,23]. Furthermore, knockouts in ClCs 3 and 7 led
to loss of hippocampal tissue and especially relevant to this work,
marked retinal degeneration [19,23]. The dramatic effects of
these knockouts on retinal tissue suggest the hypothesis that these
transporters are critical to normal retinal function and this
possibility is one motivation for our investigation into the retinal
localization of the vesicular CLCs. We are also motivated to
learn more about the vesicular CLCs in the retina because we
have previously demonstrated that nitric oxide (NO) causes the
release of Cl
2 from an internal store in cultured avian amacrine
cells and rat hippocampal neurons [24]. A functional link
between the CLCs and the effects of NO is yet to be established
but the ability of these transporters to load Cl
2 into a potentially
releasable store compels us to examine their retinal expression
pattern. Furthermore, despite the important role of certain CLC
family members in normal retinal development suggested by
analysis of knock-out mice [19,23], no systematic examination of
CLC transporter expression has yet been carried out in the
retina of any species. Here we explore the expression and
localization of ClCs 3,4,5,6 and 7 in the adult avian retina using
polyclonal antibodies raised against each of these transporters.
Double-labeling with retinal cell markers is used to further define
the cellular expression patterns for each of the proteins. We find
that each of the CLCs has a unique but sometimes overlapping
expression pattern in the avian retina. Furthermore, the CLC-
specific labeling patterns we describe are due to differences in
CLC expression among cell types as well as among sub-cellular
compartments. The specificity of CLC localization implies that
these transporters subserve specific and potentially diverse
functions in the retina.
Materials and Methods
Ethics Statement
All methods using animals in this study were approved by the
Institutional Animal Care and Use Committee, Louisiana State
University (Assurance #A3612-01).
PCR amplification
Expression of mRNAs coding for CLCs 3–7 was studied using
the reverse transcription-polymerase chain reaction method. A
mixed population of cultured chick retinal cells (embryonic
equivalent day 15) was collected in 100 ml lysis buffer+5 mlo f
0.1 mM stock dithiothreitol and 40 units (1 ml) of RNAase inhibitor
(Invitrogen, Carlsbad, CA). Isolation of mRNA was performed
using dynabeads mRNA DIRECT Micro kit (Invitrogen). cDNA
synthesis and PCR amplification was conducted in a single tube
using a one-step RT-PCR system which includes a Superscript III
one-step RT-PCR mix consisting of both platinum Taq polymer-
ase and reverse transcriptase (Invitrogen). Two sets of gene specific
primers (Table 1) were designed for each CLC type and used at a
0.5 mM concentration in the PCR reaction mixture. Efficient
cDNA synthesis was achieved with a 30 min incubation at 55uC
for CLCs 3,4,5 and 7 and the same incubation time of 30 min at a
temperature of 50uC for CLC-6. Amplification of the reverse-
transcribed cDNA was performed using a Bio-Rad C-1000
thermocycler (Hercules, CA). An initial denaturation was
conducted at 94uC for 2 min. Forty cycles of PCR were carried
out under the following conditions: Denaturing at 94uC for 15 s,
annealing at 55uC (CLC-3, 4, 5, and 7) and 50uC (CLC-6) for 30 s
and extension at 68uC for 1 min. A final extension was performed
at 68uC for 5 min. The predicted sizes of the PCR products are
listed in Table 1. The PCR products were run on a 2% agarose gel
and stained with ethidium bromide. The gel was visualized with
the Bio-Rad gel documentation system. Specificity of PCR
products was confirmed through sequencing analysis.
Western Blots
Adult White Leghorn chickens were sacrificed by intraperito-
neal injection of sodium pentobarbital (250 mg/kg, Sigma-
Aldrich, St. Louis, MO) followed by decapitation. Flash-frozen
mouse and rat tissue was provided as a gift from Dr. Jacquelyn
Stephens, Louisiana State University. Chicken, mouse, and rat
brain tissue were homogenized in lysis buffer (2% Triton X-100,
300 mM NaCl, 20 mM Tris, 2 mM EDTA, 2 mM EGTA, 1%
NP40) containing a cocktail of protease inhibitors (PMSF (1 mM),
leupeptin, (5 mg/mL) aprotinin (2.5 mg/mL), 1,10 ortho-phenan-
trolin (0.2 mg/mL) and pepstatin (0.7 mg/mL)). Samples were spun
Table 1. Primer sequences for PCR amplifications.
Primer Sequence
Product
size (bp)
Annealing
temperature
CLC3
forward
59- GGTGAAGGTGTTTGCTCCAT-39 187 bp 55u
CLC3
reverse
59-GCAGGCAACATGTACCAATG-39 187 bp 55u
CLC3
forward
59-ATGGTCAGGATGGCTCGTAG-39 209 bp 55u
CLC3
reverse
59-CTGCCCAAGTTTTCCACTGT-39 209 bp 55u
CLC4
forward
59-GGAGTACCATACCCCCTGGT-39 231 bp 55u
CLC4
reverse
59-ATCAGCTCACTGGTGCTCCT-39 231 bp 55u
CLC4
forward
59-TCAAAAGACTCGGAGCGACT-39 226 bp 55u
CLC4
reverse
59-CCACAGTCTCCATTGGTGTG-39 226 bp 55u
CLC5
forward
59-AGGAACCACTTCCTGGTGTG-39 200 bp 55u
CLC5
reverse
59-TAAGGAACCTGCCAACAACC-39 200 bp 55u
CLC5
forward
59-AGGAACCACTTCCTGGTGTG-39 235 bp 55u
CLC5
reverse
59-GTCATCCAGTGGGCAGAAAT-39 235 bp 55u
CLC6
forward
59-GGAGTGCCTCTTCTGGAGTG-39 155 bp 50u
CLC6
reverse
59-ACAGGGAAGGCATGATGAAC-39 155 bp 50u
CLC6
forward
59-TGGAGTATGCAGGGCATGTC-
AGA-39
553 bp 50u
CLC6
reverse
59- TTTCCACTGTTTCCCACTCCA-39 553 bp 50u
CLC7
forward
59-TACCGTGTGGTGAAGGACAA-39 199 bp 55u
CLC7
reverse
59-CAACATGTGGGATCTTCACG-39 199 bp 55u
CLC7
forward
59-TACCGTGTGGTGAAGGACAA-39 169 bp 55u
CLC7
reverse
59-AGCATTTGATCTGGGGAATG-39 169 bp 55u
doi:10.1371/journal.pone.0017647.t001
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using the BCA Protein Assay Kit from Pierce (Rockford, IL). For
electrophoresis, protein samples were prepared on ice in loading
buffer containing 62.5 mM Tris, 2% SDS, 10% glycerol, 5% B-
mercaptoethanol, and 0.005% bromophenol blue. Protein samples
were boiled for three minutes prior to loading on the gel. Proteins
(50–200 mg) were separated on a 7.5% SDS gel along with 10 mL
Pageruler molecular weight markers (Fermatas, Glenburnie, MD),
except for blots probed with ClC4 and ClC7 antibody, which were
run on 5% SDS gels. Proteins were transferred to nitrocellulose
membranes. Membranes were blocked overnight at 4uCi n4 %
milk and 5% normal goat serum (NGS, ClC3 and ClC5), for one
hr at room temperature in 4% milk (ClC6 and ClC7), or for one hr
at room temperature in 4% milk and 5% NGS (ClC4). Blocking
solutions were all made in tris buffered saline with 0.1% Tween 20
(TBS-T). Primary antibodies were diluted in TBS-T with 1%
bovine serum albumin (BSA). ClC6 antibody was diluted in 1%
BSA TBS-T with 5% NGS. ClC3 and ClC5 antibodies were
applied at 1:500 for one hr at room temperature. ClC4 and ClC6
were applied at 1:500 overnight at 4uC, and ClC7 antibody was
applied at 1:500 for 90 min at room temperature. Goat anti-rabbit
secondary antibody conjugated on horseradish peroxidase (Pierce,
Rockford, IL) was diluted from 1:1000–1:5000 in TBS-T with 1%
milk. Membranes were incubated in secondary antibodies for 1–
1.5 hrs at room temperature. Proteins were visualized using the
Supersignal Western Pico Reagent (Pierce).
Immunocytochemistry
Adult White Leghorn chickens were sacrificed by the same
methods indicated for Western blots. The eyes were enucleated
and hemisected. After removing the vitreous, eye cups were
immersed in 4% paraformaldehyde for 15–20 min at room
temperature. Following fixation, eye cups were washed three
times in PBS+1% Glycine. Central retina was dissected from the
eyecup and incubated in 15% sucrose for 30 min, 20% sucrose for
1 hr, and 30% sucrose solution overnight at 4uC. Retinae were
infiltrated in a 2:1 mixture of 30% sucrose and O.C.T. compound
(Sakura Finetek, Torrence, CA) for 30 min. Samples were frozen
in fresh sucrose/O.C.T. mixture on a slurry of isopentane and dry
ice. Sections (12–16 mm) were cut on a Leica CM1850 cryostat
(Wetzlar, Germany) and mounted on Superfrost Plus microscope
slides (Ted Pella, Redding, CA).
The primary antibodies used in this work are listed in Table 1
along with the source of the antibodies and the dilution at which
they were used. The monoclonal antibody to ClC-3 (cat#75-259,
clone N258/5) was developed and/or obtained from the UC
Davis/NIH NeuroMab Facility, supported by NIH grant
U24NS050606 and maintained by the Department of Neurobi-
ology, Physiology and Behavior, College of Biological Sciences,
University of California, Davis, CA 95616. In addition to the CLC
antibodies included in this table, five other commercially available
CLC antibodies were evaluated and rejected for use in this study
based on unsatisfactory Western blot results. Polyclonal antibodies
raised against peptides corresponding to regions of rat ClC4 and
ClC7 c-terminus (Alpha Diagnostics, CLC41-A and CLC71-A)
bound multiple bands at incorrect molecular weights for the
respective proteins. Polyclonal antibodies specific for internal
regions of human ClC3 and ClC5 (Santa Cruz Biotechnology, SC-
17572 and SC-22373) also gave nonspecific immunoreactive
bands. Finally, a polyclonal antibody raised against a region of
human ClC7 n-terminus gave inconsistent Western blot results
(Abcam, Cambridge, MA). Antibodies were diluted in dilution
solution consisting of phosphate-buffered saline (PBS), 1% BSA,
and 0.1% saponin. Sections were blocked in dilution solution
containing 10% NGS (Jackson ImmunoResearch Laboratories,
West Grove, PA). Primary antibodies were applied for either
72 hrs at 4uC (anti-CLC3–7, anti-nNOS, anti-calretinin, and anti-
PKCa), 1 hr at room temperature (anti-glutamine synthetase, anti-
HPC-1, anti-parvalbumin, and anti-SV2), or overnight at room
temperature (anti-ChAT). Secondary antibodies were applied for
1 hr at room temperature. Goat anti-rabbit antibodies conjugated
either to Cy3 (1:500, Millipore, Billerica, MA) or to Dylight 488
(1:100, Pierce) were used to localize polyclonal antibodies. Goat
anti-mouse antibodies conjugated to Cy3 or DyLight 488 were
used to localize the monoclonal antibodies (1:100).
Labeled sections were viewed on an inverted Leica TCS SP2
Spectral confocal microscope (Leica Microsystems, Wetzlar,
Germany) with 406and 636oil immersion objectives (1.25 and
1.4 N.A., respectively). DyLight 488 was observed with the
488 nm laser line with emission collection from 502–553 nm. Cy3
was visualized with the 543 laser line with emission collection from
572–672 nm. Images of double-labeled material were collected by
sequential scanning to minimize difficulties due to bleed through.
Images were acquired using the Leica LCS software package. All
images were collected using the same confocal laser intensity.
PMT gain was adjusted separately for each antibody except full
retinal section images of CLC single-labeled retinae where PMT
was kept the same for comparing labeling intensities of the
different CLC antibodies. For this reason, some features that are
not as clear in these images are more appreciable in later figures.
All images of single and double-labeled tissue are maximum
Figure 1. CLC H
+/Cl
2 antiporters are expressed in chicken
neurons. A, RT-PCR amplification of ClCs 3–7 mRNA from a mixed
population of cultured chick retinal neurons. Two primer pairs for each
transporter amplified single products of the expected size (in kb). B,
Western blots of chicken, rat, and mouse brain protein probed with
antibodies specific for mammalian ClCs 3–7 reveal labeling of bands at
the expected molecular weights for each protein. CB, chicken brain; RB,
rat brain; MB, mouse brain.
doi:10.1371/journal.pone.0017647.g001
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PKC and CLC and HPC-1 double labeling and some higher
magnification images. Single z plane images of these conditions
are shown to provide greater resolution of doubly immunoreactive
features and are denoted ‘‘1z’’. All fluorescent confocal images
were median-filtered using the Leica confocal software. Figures
were assembled using Adobe Photoshop CS3 (Adobe Systems Inc.,
San Jose, CA).
CLC antibody specificity in tissue sections was assessed by
comparing CLC antibody labeling of retinal sections with and
without pre-incubation with their respective antigenic peptides.
Antigenic peptides were pre-incubated with primary antibody for
1–2 hrs at room temperature, with antibody: peptide ratios of
1:1(ClC7), 1:5 (ClC4), and 1:10 (ClC5 and ClC6). Peptide exposed
sections and non-peptide exposed sections were taken from the
same retinae and were processed side by side.
IPL depth was determined by dividing the distance of
immunoreactive bands from the INL/IPL border by the total
width of the IPL as measured from its border with the INL to its
border with the GCL, following the method of Fischer et al. [25].
All IPL depth measurements are based on averages of IPL depth
from at least three retinae.
Results
CLC transporters are expressed at the mRNA level in
cultured chick retinal neurons
A previous investigation by our group revealed that nitric oxide
(NO) induces a transient elevation of cytosolic Cl
2 in cultured
chick amacrine cells and that this increase is due to Cl
2 release
from an internal compartment and not from Cl
2 crossing the
plasma membrane [24]. In an effort to identify candidate
intracellular Cl
2 transporters, PCR amplification of internally-
expressed members of the CLC family of Cl
2 channels and
transporters (ClCs 3–7) was conducted from a mixed population of
cultured retinal neurons. Primers were designed based on
predicted nucleotide sequences for chicken ClC3, ClC4, ClC5,
and ClC6 (Table 1). ClC7 primers were derived from the
referenced sequence for chicken ClC7 (Caldwell et al, 2005 [26],
Table 1). Transcripts for all CLC transporters examined were
amplified and verified through sequencing of the PCR product,
indicating that the mRNAs encoding these transporters are
expressed in cultured chicken retinal cells (Figure 1A).
CLC antibodies raised against mammalian targets
specifically label chicken CLC proteins
To examine CLC expression in the chicken retina, commer-
cially-available antibodies raised against mammalian ClCs 3–7
were obtained. Western blots of chicken brain and retina tissue
were probed with these antibodies to assess their specificity for
chicken CLCs (Table 2, Fig. 1B). An antibody raised against a
region of the rat ClC3 carboxy-terminus labeled a band near
160 kD in blots of chicken and rat brain protein (Fig. 1B). The
predicted molecular weight for ClC3 is 96 kD in chicken and
91 kD in rat. All internal CLC transporters are known to form
both homo- and hetero-dimers in expression systems [9,10,27]. It
is possible that the dominant band we observed in both species
represents ClC3 dimers. An antibody specific for rat ClC4
revealed a band between 75 and 105 kD which is close to the
predicted molecular weight of the chicken ClC4 protein (76 kD).
Unfortunately, in our hands, blots of rat and mouse brain
homogenates incubated with the same ClC4 antibody showed no
reactivity (data not shown). Nonetheless the position of the band in
chicken blots was in good agreement with that found in another
study of mouse tissue using two different polyclonal antibodies to
different regions of mammalian ClC4 protein [28]. Probing rat
and chicken brain homogenates with ClC5 antibody revealed a
band near 105 kD in the chicken and in between 75 kD and
Table 2. Antibody Information.
Antibody Host Source Catalog No. Immunogen
Working
Dilution
ClC3 Rabbit, pAb Alpha Diagnostics ClC31-A 18 aa synthetic peptide from rat C-terminus 1:500
ClC3 Mouse, mAb Neuromab clone N258/5 Synthetic peptide aa 98–115 derived from rat ClC3
(CKDRERHRRINSKKKESA)
1:500
ClC4 Rabbit, pAb Abgent AP6329f KLH conjugated synthetic peptide derived from within
aa670–695 of human ClC4
1:500
ClC5 Rabbit, pAb Alpha Diagnostics ClC51-A 13 aa synthetic peptide from within rat ClC5 aa 646–676 1:500
ClC6 Rabbit, pAb Alpha Diagnostics ClC61-A 19 aa synthetic peptide from within rat aa 840–870 1:500
ClC7 Rabbit, pAb Abcam Ab31264 Synthetic peptide derived from human ClC7
(RYRLGKRGLEELSLAQT)
1:500
Calretinin, Clone 6B8.2 Mouse, mAb Millipore MAB1568 Recombinant rat calretinin 1:100
Choline Acetyltransferase,
ChAT
Rabbit, pAb Dr. Miles Epstein 1465 Partially purified ChAT isolated from chicken optic lobes 1:1000
Glutamine Synthetase, Clone
GS-6
Mouse, mAb Millipore MAB302 Glutamine synthetase purified from sheep brain 1:500
Syntaxin 1, Clone HPC-1 Mouse, mAb Sigma S0664 Synaptosomal plasma membrane fraction from adult rat
hippocampus
1:100
nNOS, Clone NOS-B1 Mouse, mAb Sigma N2280 Recombinant rat brain nNOS, aa 1–181 1:500
Protein Kinase C, Clone MC5 Mouse, mAb Abcam Ab31 Purified bovine brain protein kinase C 1:100
SV2 Mouse, mAb Developmental Studies
Hybridoma Bank
SV2 Purified synaptic vesicles from Ommata electric organ supernatant
aa, amino acid.
doi:10.1371/journal.pone.0017647.t002
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molecular weights of ClC5 in the two species (104 kD in chicken,
83 kD in rat) and the findings in rat are similar to what has been
described by other investigators using different ClC5-specific
antibodies [29,30,31]. It is important to note that the ClC3, ClC4,
and ClC5 antibodies bound different molecular weight proteins
despite the sequence similarity of the three proteins, supporting the
specificity of each antibody for its respective target. An antibody
raised against rat ClC6 labeled a band near 160 kD in blots of
chicken and rat brain protein. The expected molecular weight for
the protein in both species is 97 kD. It seems likely that the ClC6
antibody bound ClC6 dimers, as was seen for ClC3. Two bands,
one faint band slightly above 170 kD and another stronger band
between 75 and 90 kD, were labeled in blots of chicken and rat
brain protein probed with a ClC7 antibody (expected molecular
weights are 88 kD for chicken ClC7 and 89 kD for rat ClC7). The
higher bands could represent ClC7 homodimers [27]. It is
interesting to note that the intensity of the lower band was much
stronger in chicken brain than in rat. Western blot analyses by
other groups have described similar results for ClC7 in
mammalian systems using different polyclonal antibodies [23].
These results support the expression of ClC3, ClC4, ClC5, ClC6,
and ClC7 in chicken brain tissue and, furthermore, confirm the
specificity of these mammalian-derived antibodies for these
proteins in chicken tissue.
To determine the specificity of the CLC antibodies for CLC
proteins in intact chicken retinal tissue, we labeled vertical sections
of retina with CLC antibodies that had been pre-incubated with
their respective antigenic peptides. Figure 2 shows that, in
comparison to sections not exposed to immunogenic peptide,
pre-incubation with antigenic peptide greatly reduced the labeling
intensity of antibodies against ClC4–7. An assessment of ClC3
antibody labeling block by ClC3 peptide was not done because of
the very low labeling intensity of ClC3 antibody in the chicken
retina (see Fig. 3B). It is important to note that in the case of ClC5,
pre-incubation with antigenic peptide did not reduce antibody
labeling of ganglion cells as much as in other retinal cell types
(Fig. 2B right, arrowheads) suggesting that some of this labeling
might be nonspecific. Interpretation of ClC5 antibody labeling
results in ganglion cells must therefore be made with caution.
CLC transporter expression in adult chicken retina
To determine the distribution of CLC transporters in the avian
retina, we used the polyclonal antibodies described above to label
Figure 2. CLC antibodies specifically label CLC proteins in chicken retina. A–D, Images of vertical sections of chicken retina. Each image pair
was acquired and processed identically. A, Left, ClC4 antibody labeling. Right, Pre-incubation with ClC4 peptide (P) dramatically reduced antibody
signal. B, Labeling of retinal section by ClC5 antibody (left) was substantially diminished by exposure to ClC5 peptide (right) in retinal layers, however
a slightly disproportionate signal remained in the ganglion cell layer (GCL, arrowheads). C, ClC6 antibody labeling in the presence (right) and absence
(left) of ClC6 peptide. ClC6 antibody signal was uniformly and substantially decreased by pre-treatment with peptide. D, ClC7 antibody labeling in
tissue not exposed (left) and exposed (right) to ClC7 demonstrates near total elimination of the antibody signal. (Scale for A is 50 mm and applies for
B–D as well.)
doi:10.1371/journal.pone.0017647.g002
CLC Proteins in the Chicken Retina
PLoS ONE | www.plosone.org 5 March 2011 | Volume 6 | Issue 3 | e17647Figure 3. CLC H
+/Cl
2 antiporters have diverse expression patterns in mature chicken retina. A–F, Images of vertical sections of chicken
retina. Images were acquired and processed identically except for F, which was acquired at a lower PMT gain to avoid saturation. A, Secondary
antibody only-labeled section shows minimal background fluorescence. Signal in photoreceptor outer segments and in oil droplets is
autofluorescence. B, Labeling of retinal tissue by ClC3 antibody is barely detectable. C, The ClC4 antibody labels all three nuclear layers of the retina
CLC Proteins in the Chicken Retina
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antibody labeling in the mature chicken retina revealed
differences in expression patterns among internally expressed
CLC transporters. The micrographs in Figure 3A–F were all
obtained using the same acquisition settings and brightness
adjustments were made identically, with the exception of ClC7
which was acquired at a lower PMT gain to avoid saturation of
the fluorescent signal. Figure 3A shows a section of chicken retina
labeled only with secondary antibody. Fluorescent signal was
restricted to photoreceptor oil droplets and outer segments, which
are well-characterized auto-fluorescent features in the chicken
retina (Fig. 3A). These photoreceptor components are often lost
during tissue preparation and sectioning; as such, their presence
is variable in later figures.
ClC3
The polyclonal antibody raised against ClC3 c-terminus gave
minimal labeling in vertical sections of chicken retinal tissue.
Comparison to a control section obtained with the same
acquisition settings (secondary antibody only, Figure 3A) showed
that ClC3 antibody labeling was barely above background levels
and was mainly restricted to the nuclear layers of the retina, where
cell bodies reside (Fig. 3B, H, and N). A monoclonal antibody
specific to a region of rat ClC3 n-terminus (identical to the chicken
sequence) also minimally labeled chicken retina (Fig. S1) further
supporting a low level of ClC3 expression in chicken retina.
ClC4
A vertical section of retinal tissue labeled with ClC4 antibody
showed that ClC4 was widely expressed in the nuclear and
plexiform (synaptic) layers of the retina (Fig. 3C). Most immuno-
reactivity in the photoreceptors was limited to the outer nuclear
layer (ONL), and labeling in the inner nuclear layer (INL) was
stronger in the inner half of the INL (Figure 3C). Most cells in the
ganglion cell layer(GCL) wereClC4 positive.Intheouter plexiform
layer (OPL), where photoreceptors make synapses with bipolar cells
and horizontal cells, ClC4 antibody label was diffuse (Fig. 3I). In the
inner retina, some ClC4 positive processes could be seen emanating
from the INL into the distal (furthest from GCL) inner plexiform
layer (IPL, Fig. 3O, arrows). In addition, there were two broad
bands of ClC4 labeling in the IPL at 20–35% and 55–75% IPL
depth as well as a thinner third band at approximately 95% IPL
depth (Fig. 3O,1–3, seeMethods).Finally, veryfaint ClC4 antibody
labeling was detected in the nerve fiber layer (NFL), which is
primarily composed of ganglion cell axons (Fig. 3C).
ClC5
Of all of the CLC antibodies examined in the adult chicken
retina, the ClC5 had the broadest expression pattern. Similar to
ClC4, the ClC5 antibody labeled tissue in all of the synaptic and
nuclear layers of the adult chicken retina (Fig. 3D). However, the
intensity of the labeling was much greater than that of ClC4. ClC5
expression was widespread in both photoreceptor inner segments
and the outer nuclear layer, and there was particularly intense
labeling of the outer limiting membrane (OLM, Fig. 3D, arrow).
In the INL, the ClC5 labeling pattern was similar to that of ClC4,
with more antibody signal in that layer concentrated in the inner
half of the INL. As with anti-ClC4, ClC5 antibody labeled most
cells in the GCL. ClC5 was expressed in the synaptic layers of the
retina. ClC5 labeling was diffusely distributed throughout the OPL
and was also found in scattered processes (Fig. 3J, arrowheads). In
the inner retina, some isolated, thin ClC5-positive processes were
observed extending vertically from the INL into varying depths of
the IPL (Fig. 3P, arrows). ClC5 antibody also labeled processes in
the distal IPL in a broad band extending from 0–25% IPL depth
(Fig. 3P, 1) as well as three thin bands located at approximately
50% (Fig. 3P, 2), 60% (Fig. 3P, 3), and .90% (Fig. 3P, 4) IPL
depths, with a fifth band at 70% IPL depth discernable in some
sections (Fig. 3P, arrowhead). Finally, many process in the NFL
were intensely labeled by the ClC5 antibody (Fig. 3D).
ClC6
Like ClC3, the labeling intensity of the ClC6 antibody in the
retina was much weaker than that of ClC4 and ClC5, though
expression was faintly discernable in all of the nuclear and
plexiform layers (Fig. 3E). Interestingly, however, ClC6 antibody
labeling was more intense in photoreceptors and in puncta in the
OPL (Fig. 3K, arrows). Furthermore, the photoreceptor labeling
was restricted to vertical elements distributed diffusely in the
proximal portion of photoreceptor inner segments and the distal
portion of the ONL (Fig. 3E, arrowheads). This labeling was very
different in appearance from the labeling of the OLM by the ClC5
antibody (Fig. 3D). Though the labeling intensity of the ClC6
antibody was weak in the IPL, three faint bands of immunore-
activity could be observed at approximately 20%, 65%, and
.90% IPL depth (Fig. 3Q, 1–3). Panel brightness was enhanced to
bring out ClC6 IPL expression (Fig. 3M and N showing no
primary and ClC3 labeling were adjusted the same way). ClC6
antibody labeling was not observed in the NFL.
ClC7
ClC7 antibody labeling was strong in most layers of the retina,
but the labeling pattern was more punctate than that of the other
CLCs (Fig. 3F). In photoreceptors, ClC7 labeling was distributed
in bright puncta in photoreceptor inner segments as well as in
vertical elements (Fig. 3F, arrowheads) around the inner segment/
ONL border. However, ClC7 signal was very weak in the rest on
the ONL (Fig. 3F). ClC7 immunoreactivity was strong in the outer
and inner INL, but there was a band in roughly the center of the
layer nearly devoid of labeling (Fig. 3F, white arrow). Bright
punctate labeling was more or less evenly distributed in the outer
INL whereas in the inner INL, ClC7 signal appeared to be
particularly concentrated in some triangular cell bodies at the
INL/IPL border (Fig. 3F, asterisks). Some of these triangular cells
had puncta of ClC7 labeling in thick processes projecting into the
IPL (Fig. 3F, yellow arrows). ClC7 labeling was observed in most
and the IPL. D, ClC5 antibody labeling in nuclear and synaptic layers. Arrow indicates ClC5 expression in the OLM. E, The ClC6 antibody labeled
vertical elements in photoreceptors (arrowheads). F, Punctate ClC7 signal in nuclear and synaptic layers. Asterisks and yellow arrows indicate ClC7+
cells at INL/IPL border. White arrow indicates INL band lacking ClC7. G–L, Zoom of CLC antibody labeling in the OPL from the same sections shown in
A–F. Images have been individually adjusted to highlight immunoreactive features. ClC5 expression is widespread and diffuse and in scattered
processes (arrowheads) whereas ClC6 antibodies label discrete puncta. ClC4 and ClC7 antibody signals are fainter, and ClC3 signal is absent from the
OPL. M–R, Zoomed images of anti-CLC labeling in the IPL. Images have been individually adjusted. IPL labeling by ClC3 antibody was minimal. ClC4
antibody labels horizontal processes in outer IPL (arrows) and three distinct bands (1–3). ClC5 is expressed in vertical processes projecting to central
IPL (arrows) and four (1–4) to five (arrowhead) bands. Three bands of ClC6 immunoreactivity (1–3) are distinguishable. ClC7 antibody labels one band
in outer IPL (1) and one band in inner IPL (2). 3 indicates a thin IPL band lacking ClC7. (Scale bar in A is 50 mm and applies to B–F. Scale bar in G is
5 mm and applies to H–L. Scale bar in M is 50 mm and applies to N–R.)
doi:10.1371/journal.pone.0017647.g003
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PLoS ONE | www.plosone.org 7 March 2011 | Volume 6 | Issue 3 | e17647Figure 4. ClC4 is expressed in calretinin-positive horizontal cells and PKC-positive bipolar cells. A–C, Vertical section of mature chicken
retina double-labeled with antibodies specific for ClC4 and calretinin. ClC4 antibody labeling co-localizes with anti-calretinin labeling in horizontal
cells and amacrine cells (arrow) and cells in the GCL. White arrowheads indicate IPL bands immunoreactive for both antibodies. Yellow arrowheads
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PLoS ONE | www.plosone.org 8 March 2011 | Volume 6 | Issue 3 | e17647cell bodies of the ganglion cell layer. ClC7 expression was diffusely
distributed in the outer plexiform layer (Fig. 3L). In the IPL, there
was a band of ClC7 immunoreactivity at approximately 15%
depth (Fig. 3R, 1) and a thicker band between 30% and 90%
depth (Fig. 3R, 2). Visible in some sections, including the one
shown in Figure 3, was a narrow strip within this thicker band
lacking ClC7 antibody label at approximately 70% IPL depth
(Fig. 3R, 3). Interestingly, no ClC7-positive band was ever
observed near the GCL (.90% IPL depth), a feature shared by
ClC4–6. Scattered processes in the NFL were faintly ClC7-positive
(Fig. 3F).
To determine the retinal cell types expressing different CLC
transporters, we double labeled retinal tissue with the CLC
transporter antibodies and antibodies raised against cell-type
specific markers. Due to the low level of ClC3 antibody labeling in
the chicken retina (see Fig. 3), we focused on characterizing the
expression patterns of ClC4–7.
Cell-type specific markers for chicken retina
From the literature, we identified a suite of marker proteins with
established cell-type specific expression in chicken retina. Exposing
retinal sections to monoclonal antibodies raised against these
proteins gave results in good agreement with what has been
previously reported by other groups using in the chicken retina.
Below, we describe the labeling patterns of these antibodies and
the cell-type specific expression of their target proteins in the
chicken retina.
Calretinin is a calcium-binding protein expressed in a majority
of horizontal cells as well as in subsets of bipolar cells, amacrine
cells, and ganglion cells in the chicken retina [32,33]. We used a
monoclonal calretinin antibody raised against recombinant rat
calretinin (.80% identity with chicken calretinin protein) to label
calretinin expressing cells in vertical sections of chicken retinal
tissue. Here, we used a monoclonal calretinin antibody to identify
horizontal cells.
A monoclonal antibody specific for the alpha and beta isoforms
of protein kinase C (PKC) has been shown to label two populations
of chicken bipolar cells [34,35], and our results with this antibody
were similar to descriptions of PKC expression in the retina in
these studies and in one using a different PKC antibody [36].
The HPC-1 monoclonal antibody binds syntaxin 1, a protein
known to be expressed in amacrine cells and not in ganglion cells
or bipolar cells [37,38]. This antibody has been extensively used as
a specific marker for amacrine cells in a number of different
species, including the chicken [39].
Glutamine synthetase (GS) converts ammonia and glutamate
into glutamine and is a useful glial cell marker in the central
nervous system. In the chicken retina, GS is expressed by Mu ¨ller
glial cells [40,41] and possibly by another population of astrocyte-
like glial cells in the GCL and NFL [42]. We used a monoclonal
antibody specific for glutamine synthetase to selectively label
Mu ¨ller cells in the chicken retina.
Our interest in understanding the role of CLCs in the NO-
dependent release of Cl
2 from internal stores motivated us to
examine the relative distribution of CLC transporters and the
neuronal isoform of nitric oxide synthase (nNOS), an enzyme
responsible for catalyzing the synthesis of NO in the presence of
calcium and calmodulin in the CNS. In a previous investigation of
nNOS expression in chicken retina, Fischer et al [43] described
four distinct types of nNOS positive amacrine cells using two
different polyclonal nNOS antibodies. They also observed nNOS
expression in efferent target cells (ETCs), in several bands of the
IPL, in the OPL, and in a subset of ganglion cells and
photoreceptors. Using a different polyclonal nNOS antibody in
a later study, we found a similar expression pattern [44]. Here, we
used a monoclonal nNOS antibody that strongly co-localized with
the polyclonal nNOS antibody from the 2003 study (data not
shown) to label nNOS-expressing cells in the retina.
SV2 is expressed in photoreceptor terminals, but not in
horizontal cells in the chicken retina [45] and a monoclonal
SV2 antibody has been used as a marker for photoreceptor
terminals in chicken retina [46,47]. In the current work, we used
the monoclonal antibody specific for SV2 to examine the
localization of ClC6 expression in the OPL.
The labeling pattern of a polyclonal choline acetyltransferase
(ChAT)-specific antibody has been well characterized in the
chicken retina [25,48]. Here, we used the same ChAT antibody to
examine the expression of CLC transporters in cholinergic
amacrine cells.
ClC4 is expressed in calretinin-positive horizontal cells
Figures 4B and E show that horizontal cell labeling with the
monoclonal calretinin antibody was in good agreement with the
findings of Fischer et al [33] and Ellis et al [32]. In Figure 4E, a
high magnification image, acquired at a lower gain than the
image shown in 4B, shows intensely-labeled, calretinin-positive
horizontal cells as well as diffuse immunoreactivity in 2–3 strata
of the OPL. Labeling of putative bipolar cells, amacrine cells, and
ganglion cells was also similar to that found in these previous
investigations, but certain elements in the IPL were less well-
resolved, perhaps due to the monoclonal nature of the antibody.
ClC4 antibody labeling co-localized with the calretinin signal in
horizontal cells (Fig. 4D–F, asterisks) as well as in strongly
calretinin-positive cell bodies near the INL/IPL border (Fig. 4A–
C, white arrow) and in more weakly immunoreactive cells in the
inner half of the INL and in the GCL. Note that ClC4 was
expressed in calretinin-negative horizontal cells as well (Fig. 4D–
F, white arrow). The calretinin antibody also labeled processes
projecting from the INL to a narrow band of immunoreactivity
centered on 55% IPL depth (Fig. 4B, yellow arrowheads) as well
as two much fainter, broad bands in the IPL, one centered
around 25% and one centered around 90% IPL depth (Fig. 4B,
white arrowheads). There was some overlap of ClC4 and
calretinin expression in the distal and proximal IPL, but not,
interestingly, in the middle band (55% IPL depth) of calretinin
immunoreactivity, which, in Figure 4B and C is the most clearly
resolved calretinin-positive IPL band (yellow arrowheads). Co-
localization of ClC4 and calretinin in the OPL was minimal
(Fig. 4D–F).
indicate an IPL band immunoreactive only for the calretinin antibody. D–F, Lower gain, higher magnification images of horizontal cell labeling by
ClC4 and calretinin antibodies show that ClC4 is expressed in both calretinin-positive (asterisks) and calretinin-negative (arrow) horizontal cells. G–I,
Chicken retinal tissue labeled with the ClC4 antibody and with an antibody specific for PKC reveal overlapping ClC4 and PKC expression. Arrowheads
indicate that PKC-positive bands in the IPL overlap with ClC4 IPL immunoreactivity. Boxes indicate ClC4-negative, PKC-positive bipolar cell terminals.
J–L, Higher magnification, single z plane images of a different PKC and ClC4 antibody labeled section. Co-localization of ClC4 and PKC antibody in the
OPL supports expression of ClC4 in bipolar cell dendrites (arrows). M–O, Images from a single z plane from the same z stack as in G–I. P–R, Zoomed
in images of the blue-bordered area in M–O confirm that ClC4 is expressed in PKC-positive bipolar cell bodies (asterisks) in the chicken retina. (Scalei n
A–C, G–I, and M–O, 50 mm; in D–F, J–L, and P–R, 10 mm.)
doi:10.1371/journal.pone.0017647.g004
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To determine whether ClC4 is expressed in bipolar cells of the
chicken retina, we double labeled retinal sections with ClC4
antibody and PKC antibody. Figures 4H (projection image of a
stack of twenty z planes through the retinal cross-section) and 4N
and Q (images of a single z plane from the same stack) show that
the PKC antibody strongly labeled a small number of cell bodies in
the middle of the INL with projections to the OPL and IPL and
more faintly labeled a larger number of cell bodies in the distal half
of the INL (Fig. 4H). A few scattered cell bodies close to the INL/
IPL border were also faintly PKC positive, possibly representing
PKC-expressing amacrine cells (Fig. 4H, [36]). In the OPL, two
bands of PKC immunoreactivity were observed (Fig. 4K, high
magnification image of a single plane from a different retinal
section). In the IPL, there were three distinct layers of PKC
positive bipolar cell terminals at approximately 0–10%, 45%, and
80% IPL depth (ovals, Fig. 4H) as well as three much weaker
bands of immunoreactivity at 30%, 70%, and 92% IPL depth
(arrowheads, Fig. 4H). Figures 4P–R show that the brightly
labeled, PKC positive cell bodies in the INL were also labeled with
ClC4 antibody (asterisks). ClC4 antibody signal was typically
surrounded by PKC antibody signal in these cells. PKC and ClC4
displayed some overlapping expression in the OPL although the
ClC4 antibody labeling there was more diffuse than the PKC
labeling (Fig. 4J–L, white arrows). In the IPL, ClC4 did not co-
localize strongly with PKC in bipolar cell terminals (Fig. 4G–I,
boxes). However, the two antibodies did appear to overlap in the
more weakly PKC-positive IPL bands (Fig. 4G–I, arrowheads).
Taken together, these results suggest that ClC4 is expressed in at
least two populations of bipolar cells in the chicken retina as well
as in PKC-positive bands in the IPL.
ClC4 is expressed in retinal amacrine cells
The labeling of the proximal half of the INL (closest to the IPL)
by the ClC4 antibody (Fig. 3C) suggests that this protein may be
expressed in retinal amacrine cells. To examine the expression of
ClC4 in amacrine cells, we double-labeled chicken retinal sections
with ClC4 antibody and the antibody specific for syntaxin 1 (HPC-
1). Figures 5B and 5E (asterisks) show HPC-1 antibody labeling in
the cell membranes of cell bodies in the inner half of the INL.
There was also extensive labeling throughout the IPL as well as
fainter labeling in the OPL in putative horizontal cell terminals
[49]. Scattered cell bodies in the GCL, representing displaced
amacrine cells, were also labeled (Fig. 5H, asterisk). All HPC-1
expressing cells in the INL and GCL also appeared to express
ClC4, confirming that ClC4 is expressed in retinal amacrine cells
(Fig. 5C, F, and I).
ClC4 is expressed in glial cells in the chicken retina
Figures 5J–L show a retinal tissue section double labeled with
ClC4 antibody and the monoclonal antibody specific for
glutamine synthetase (GS). In Figure 5K, a projection image of
a retinal section labeled with a GS-specific monoclonal antibody
showed the expected pattern of labeling in Mu ¨ller cells [41], with
GS expression in processes stretching from the OLM to the inner
limiting membrane (ILM, not shown) that thickened in putative
perikarya in the center of the INL. ClC4 and GS antibody signals
co-localized in some areas of the INL and outer retina, specifically
in Mu ¨ller cell perikarya (Fig. 5J–L, white arrows) and in glial
processes in the OPL and ONL, indicating that ClC4 is expressed
in Mu ¨ller cells of the chicken retina.
ClC4 transporters are present in nNOS-expressing cells in
the retina
To examine ClC4 expression in retinal cells containing nNOS,
we double-labeled retinal tissue with monoclonal nNOS antibody
and ClC4 antibody (Fig. 5M–R). ClC4 antibody signal co-
localized with that of nNOS in the ONL, putative horizontal cells
(Fig. 5M–O, yellow arrows), Mu ¨ller cells (Fig. 5P–R, arrowheads),
some amacrine cell bodies and processes at the INL/IPL border
(Fig. 5O and R, white asterisk and arrows) and putative efferent
target amacrine cells (ETCs, [43], Fig. 5O, yellow asterisk). ClC4
and nNOS expression also overlapped in the ClC4 positive band
closest to the GCL (Fig. 5M–O, arrowheads). ClC4 and nNOS
were also both expressed in the GCL. Taken together, these
results support the possibility of interaction between ClC4
proteins and NO produced in nNOS-expressing cells in the
chicken retina.
ClC5 is expressed in calretinin-positive horizontal cells
To begin to examine ClC5 expression in the outer retina, we
double-labeled retinal tissue with ClC5 and calretinin antibodies.
All calretinin-positive horizontal cell bodies were also ClC5-
positive, and processes in the OPL were labeled by both
antibodies, confirming that ClC5 was expressed in most horizontal
cells in the chicken retina (Fig. 6A–F). In addition, images of a
retinal cross section labeled with the ClC5 and calretinin
antibodies (Fig. 6A–C) demonstrated co localization of ClC5 and
calretinin in cell bodies in the inner half of the INL and in the
GCL. INL cell bodies brightly labeled with calretinin antibody
were also faintly labeled with ClC5 antibody (Fig. 6A–C, white
arrows). Calretinin and ClC5 antibodies also overlapped in
putative glial cell processes and perikarya in the INL, OPL, and
ONL (Fig. 6A–C). ClC5 antibody labeling co-localized with
calretinin expression in the outer and inner calretinin-positive IPL
bands (Fig. 6A–C, white arrowheads), but not as much in the
central IPL band (Fig. 6A–C, yellow arrowheads). However, some
individual neuronal processes projecting to the middle of the IPL
were labeled with both antibodies (Fig. 6A–C, yellow arrows).
Finally, we observed co-labeling of the two antibodies in many
ganglion cell axons as well.
Figure 5. ClC4 is expressed in amacrine cells, Mu ¨ller glia, and nNOS-positive cells. A–C, Single z plane images of chicken retinal tissue
sections double-labeled with antibodies specific for ClC4 and the amacrine cell marker, HPC-1 reveal that ClC4 is expressed in the HPC-1-positive cells.
D–F, Zoom images of ClC4 and HPC-1 antibody labeling of the blue box region in A–C. ClC4 is expressed in amacrine cells, predominantly at cytosolic
locations (asterisks). G–I, Zoomed images of the purple box region in A–C show that ClC4 is expressed in displaced amacrine cells in the retina
(asterisk). J–L, Retinal tissue double-labeled with ClC4 antibody and an antibody specific for the Mu ¨ller cell marker, glutamine synthetase (GS). Arrows
indicate examples of ClC4 expression in Mu ¨ller glia. M–O, Retinal sections double-labeled with ClC4 antibody and a nNOS-specific antibody. The
nNOS antibody labels cells in all layers of the chicken retina, with strong labeling of horizontal cells (yellow arrows), a subset of amacrine cells and
processes (white asterisk) as well as putative Mu ¨ller cells, efferent target cells (ETCs, yellow asterisk), IPL processes (white arrows) and bands, ganglion
cells, and scattered processes in the NFL. ClC4 is expressed in almost all nNOS-expressing cells. Note co-localization of ClC4 and nNOS in an
immunoreactive band near to the IPL/GCL boundary (arrowheads). P–R, Single z plane zooms of ClC4 and nNOS antibody labeling confirms co-
labeling of glial cells (arrowheads) and IPL processes (white arrows). (Scale in A, 50 mm, applies to B–C, J–L, and M–O; Scale D–F, 15 mm; Scale G–I,
15 mm; Scale P–R, 15 mm.)
doi:10.1371/journal.pone.0017647.g005
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PLoS ONE | www.plosone.org 11 March 2011 | Volume 6 | Issue 3 | e17647Figure 6. ClC5 is expressed in calretinin-positive horizontal cells and PKC-positive bipolar cells. A–C, Retinal tissue sections double-
labeled with ClC5 and calretinin antibodies. ClC5 antibody labeling co-localizes with that of calretinin in horizontal cells and amacrine cells (cell body,
white arrow; process, yellow arrow). White arrowheads indicate IPL bands immunoreactive for both antibodies. Yellow arrowheads indicate an IPL
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Consistent with ClC5 expression in chicken bipolar cells, double
labeling of retinal sections with ClC5 and PKC antibodies
revealed overlapping expression of the two proteins in bipolar
cell bodies in the outer half of the INL (Fig. 6L and R, asterisks).
PKC-positive cell bodies in the inner INL were also labeled with
ClC5 antibody, suggesting that amacrine cells that express PKC
also express ClC5 (Fig. 6G–I, white arrow). In single plane images
of the OPL (Fig. 6J–L), the ClC5 antibody signal co-localized with
that of PKC in bipolar cell dendrites. ClC5 and PKC antibody
labeling also overlapped in Mu ¨ller cell processes projecting to the
OLM (Fig. 6J–L, arrowhead). In the IPL, in contrast to our ClC4/
PKC co-labeling observations, overlapping ClC5 and PKC
antibody labeling was only observed in the immunoreactive band
nearest to the GCL (arrowheads). The other PKC- and ClC5-
positive bands were intercalated in the IPL, and ClC5 was not
present in bipolar cell terminals (Fig. 6G–I, boxes).
ClC5 transporters are expressed in retinal amacrine cells
In order to confirm ClC5 expression in retinal amacrine cells,
we used the HPC-1 antibody to selectively label amacrine cells.
Figures 7A–I show single z plane images of tissue sections doubled-
labeled with HPC-1 antibody and ClC5 antibody. HPC-1 signal
enveloped ClC5 signal in cell bodies in the INL and GCL,
indicating that, as with ClC4, ClC5 was expressed by amacrine
cells in the INL and displaced amacrine cells in the GCL.
ClC5 transporters are expressed in Mu ¨ller glia
To determine whether ClC5 is expressed in glial cells, glutamine
synthetase antibody was used to selectively label Mu ¨ller cells in
chicken retinal cross sections (Fig. 7J–L). In this section, ClC5
antibody labeling co-localized with that of glutamine synthetase,
indicating that ClC5 is expressed in Mu ¨ller cells (Fig. 7J–L, white
arrows). ClC5 and glutamine synthetase antibody labeling also
strongly overlapped in the OLM (Fig. 7J–L, arrowheads).
nNOS expressing cells also express ClC5
We have demonstrated widespread overlapping ClC4 and
nNOS expression in the adult chicken retina. Is ClC5 localized to
nNOS-expressing cells in the retina as well? Figures 7M–O show
ClC5 antibody labeling in nNOS-positive amacrine cells (aster-
isks), in Mu ¨ller cells (yellow arrowheads), in scattered processes and
puncta near the INL/IPL border (arrows), and in ganglion cells. In
the IPL, CLC5 immunoreactive bands were also immunoreactive
for nNOS (white arrowheads). Taken together, these results
support the possibility of interaction between ClC5 transporters
and NO produced in nNOS-expressing cells.
ClC6 is expressed in photoreceptor terminals
In comparison to other CLC transporters, ClC3 and ClC6 did
not appear to be widely expressed in the avian retina (Fig. 3). ClC3
antibody labeling was uniformly weak in all regions of the chicken
retina. However, ClC6 antibody labeling, though low in most
parts of the retina, was intense in vertical elements in
photoreceptors and somewhat more modestly present in the
OPL. To further examine ClC6 expression in the OPL, retinal
tissue sections were double labeled with ClC6 antibody and the
monoclonal antibody to the synaptic vesicle protein SV2. Figure 8
shows SV2 antibody labeling in the OPL and IPL in cross-sections
of retinal tissue. A higher magnification image revealed SV2
antibody labeling in the OPL is restricted to crescent-shaped
elements consistent with photoreceptor terminals (Fig. 8E). Some
of these SV2 positive elements overlapped with ClC6 antibody
label (Fig. 8F, arrows), suggesting that ClC6 is expressed in
photoreceptor terminals in the chicken retina.
ClC7 is not expressed in calretinin-positive horizontal
cells
Images of tissue sections double-labeled with antibodies specific
for calretinin and ClC7 show that, unlike ClC4 and ClC5, ClC7 is
not expressed in calretinin-positive horizontal cells (Fig. 9D–F,
asterisks). In addition, there was virtually no labeling of calretinin-
expressing amacrine cells by the ClC7 antibody (Fig. 9A–C,
arrowheads). However, calretinin-positive ganglion cells were also
ClC7-positive. Finally, the labeling patterns of the two antibodies
did not overlap appreciably in Mu ¨ller cells or in the synaptic layers
of the retina.
ClC7 is expressed in PKC-positive bipolar cells at putative
membrane locations
To further characterize ClC7 expression in the retina, we next
examined ClC7 antibody labeling in bipolar cells labeled with the
antibody specific for PKC. In Figures 9P–R, PKC-positive bipolar
cells were faintly labeled by ClC7 antibody (asterisk), indicating
that at least a subset of bipolar cells in chicken retina expresses
ClC7. However, in these cells, ClC7 antibody label was confined
to the margins of the cell body, perhaps in close association with
the plasma membrane, an observation that differed from the
internal cell body expression observed with ClC4 and ClC5.
Furthermore, ClC7 antibody did not label PKC-expressing
bipolar cell projections to the OPL or PKC-positive puncta in
the OPL (Fig. 9J–L). In the inner retina, ClC7 expression did not
overlap with PKC expression in the IPL (Fig. 9G–I), but ClC7-
positive cells in the ganglion cell layer were also labeled by the
PKC antibody.
ClC7 is expressed in retinal amacrine cells
Figures 10A–I show retinal tissue double-labeled with ClC7
antibody and with the amacrine cell marker antibody, HPC-1.
Zoomed-in images of the INL (Fig. 10D–F) and the GCL
(Fig. 10G–I) revealed ClC7 antibody labeling in amacrine cell
bodies, confirming ClC7 expression in retinal amacrine cells.
ClC7 is not widely expressed in retinal glial cells
Using an antibody specific for GS to selectively label glial cells,
we observed some co-localization of ClC7 and GS antibodies in
band that is only immunoreactive for the calretinin antibody. D–F, Lower gain, higher magnification images from a different double-labeled tissue
section show that ClC5 is expressed in calretinin-positive horizontal cell bodies (asterisks) and processes (arrowheads). G–I, Retinal sections labeled
with the ClC5 antibody and an antibody specific for PKC reveal overlapping ClC5 and PKC expression. Arrowheads indicate that PKC-positive bands in
the IPL overlap with ClC5 IPL immunoreactivity only in the band nearest the GCL. White arrow indicates putative PKC-positive amacrine cell. Boxes
indicate ClC5-negative, PKC-positive bipolar cell terminals. J–L, Higher magnification, single z plane images of ClC5 and PKC antibody labeling in the
OPL and outer INL in a different tissue section. ClC5 and PKC antibody signals are co-localized in bipolar cell bodies (asterisks) and OPL projections
(arrow) as well as in glial projections (arrowhead). M–O, Images from a single z plane from the same z stack as in G–I. P–R, Zoom in of the blue-
bordered area in M–O confirms that ClC5 is expressed in PKC-positive bipolar cell bodies (asterisk) in the chicken retina. (Scale A–C, 50 mm, applies for
G–I and M–O as well; Scale D–F, 10 mm; Scale J–L, 15 mm; Scale P–R, 10 mm.)
doi:10.1371/journal.pone.0017647.g006
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L, arrows), but the ClC7 antibody labeling was very discrete and
punctate and could have represented ClC7 expression in closely
associated amacrine cells. Furthermore, ClC7 and glutamine
synthetase antibody signals did not overlap in glial processes.
Thus, ClC7 may be expressed in Mu ¨ller glia in the chicken retina,
but its expression pattern in these cells is much more restricted
than that of ClC4 and ClC5.
ClC7 is not widely expressed in nNOS-positive cells in the
retina
To examine ClC7 transporter expression in nNOS-expressing
cells, retinal tissue sections were double-labeled with antibodies to
nNOS and ClC7. Figures 10M–O show that compared to ClC4
and ClC5, co-localization of ClC7 and nNOS was not very striking.
This apparent difference was partially due to more restricted ClC7
expression in glial cells and partially due to the more discrete nature
of the ClC7 signal. ClC7 antibody sparsely labeled nNOS-
expressing photoreceptors, putative ETCs, and cells in the GCL
(Fig. 10M–O). nNOS-positive processes and bands in the IPL were
not labeled by ClC7 antibody. The triangle-shaped, strongly ClC7-
positive cells at the INL/IPL border were not nNOS-positive.
ClC5 and ClC7 are expressed in cholinergic cells in the
retina
We have shown that both ClC5 and ClC7 were expressed in
amacrine cells near the INL/IPL border and in displaced
amacrine cells in the GCL (Fig. 7A–I, Fig. 10A–I). We have also
shown that both antibodies labeled thin bands in the distal IPL
(Fig. 3D and F). To further examine which types of amacrine cells
express ClC5 and ClC7, we double-labeled chicken retinal tissue
sections with antibodies to ChAT and the two CLC proteins. In
our hands, the polyclonal ChAT antibody gave the expected
labeling pattern in the inner retina, with two layers of widely
spaced, brightly labeled cell bodies in the inner half of the INL and
a layer of cells in the GCL sending projections out to IPL bands at
approximately 20% and 65% depth, respectively (Fig. 11B and E).
Because the ClC7 antibodies and the ChAT antibody were all
raised in rabbit and because the only commercially available
monoclonal ChAT antibody that we were able to find did not label
bands in the IPL (Clone 1e6, data not shown), we performed
sequential double labeling experiments in which the double
labeled tissue was compared to side-by-side single-labeled controls.
Figures 11A–C show that all ChAT-positive cells were also ClC5-
positive (arrows) and that two of the ClC5 antibody-labeled bands
in the IPL overlapped with the two ChAT-positive bands
(arrowheads). These results are not surprising given that ClC5
seemed to be present to some degree in virtually all amacrine cells
(See Figure 7A–I). Interestingly, however, ClC7 antibody labeling
appeared to be particularly intense in ChAT-positive amacrine
cells (arrows, Fig. 11D–F), suggesting that the protein might have a
particular function in these cells. The thin outermost ClC7-
positive IPL band was also labeled with ChAT antibody
(arrowheads).
Figure 7. ClC5 is expressed in amacrine cells, Mu ¨ller glia, and nNOS-positive cells. A–C, Single z-plane images of chicken retinal tissue
sections double-labeled with ClC5 and HPC-1 antibodies reveal that ClC5 is expressed in the HPC-1-positive cells. D–F, Zoom of ClC5 antibody
labeling of blue box region in A–C shows that ClC5 is expressed cytosolically in amacrine cells (asterisks). G–I, Zoom of purple box region in A–C
shows ClC5 antibody labeling in the ganglion cell layer, indicating that ClC5 is expressed in displaced amacrine cells in the retina (asterisk) as wella s
in neighboring, HPC-1 negative ganglion cells. J–L, Sections of retinal tissue double-labeled with ClC5 and GS antibodies show that GS and ClC5 co
localize in Mu ¨ller cells (arrows) and in the OLM (arrowheads). M–O, Retinal sections double-labeled with ClC5 and nNOS antibodies reveal expression
of ClC5 in nNOS-expressing cells. Yellow arrowheads and asterisks indicate overlapping signal in Mu ¨ller cells and amacrine cells, respectively. Arrows
indicate co-expression in puncta near the INL/IPL border, and white arrowheads indicate co-localization in three bands in the IPL. (Scale A–C, 50 mm,
applies to J–L and M–O as well; Scale D–F, 15 mm; Scale G–I, 15 mm.)
doi:10.1371/journal.pone.0017647.g007
Figure 8. ClC6 is expressed in photoreceptor terminals in the OPL. A–C, A vertical section of adult chicken retina double-labeled with ClC6
and a monoclonal antibody specific for the synaptic vesicle protein, SV2 (Scale, 50 mm). Note ClC6-positive vertical elements near the OLM as well as
ClC6-positive puncta in the OPL. D–F, Higher magnification images of the OPL. Arrows indicate expression of ClC6 in photoreceptor terminals. (Scale
D–F, 15 mm).
doi:10.1371/journal.pone.0017647.g008
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Our investigation of CLC transporter expression revealed
distinctive differences in the expression pattern of these proteins
in the chicken retina (Fig. 12). Though there is evidence for CNS
expression of all five CLC family members examined
[15,17,20,28,50], this is the first study, to our knowledge, of
relative CLC expression by different cell types within a single
nervous system tissue.
Retinal expression of ClC3 and ClC6
Our results suggest that ClC3 expression is weak and ClC6
expression is primarily localized to a restricted region of
photoreceptors. This was a surprising result because ClC6 is
known to be widely expressed in the nervous system [17] and
ClC3 is necessary for normal retinal development [19] in mouse
retina. In the case of ClC6, existing studies examining CNS
expression of this protein did not look at retinal expression
explicitly so it is possible that ClC6 distribution in the retina differs
from that of other areas of the CNS. ClC3, however, has been
shown to be expressed in synaptic layers of the mouse retina
[19,50] in contrast to our finding of low apparent ClC3 expression
in chicken retina. It is possible that this difference reflects a true
species difference. It is also possible that our ClC3 antibody did
not have the same level of affinity for the protein. Arguing against
this interpretation, a monoclonal antibody specific for a different
region of the ClC3 protein also minimally labeled the chicken
retina. Furthermore, this monoclonal antibody was raised against
the same region of rat ClC3 as the polyclonal antibody that
strongly labeled the synaptic layers of mouse retina in refs.19 and
50. The antigens used to synthesize both ClC3 antibodies were
derived from portions of the rat protein sequence that are 100%
identical to the predicted chicken amino acid sequence for ClC3.
Diverse CLC expression patterns in photoreceptors
There is a high degree of variability in photoreceptor expression
among ClCs 4–7. ClC7 is expressed in photoreceptor inner
segments but is virtually absent from the ONL, whereas ClC4 is
only expressed in the ONL. ClC5 is expressed throughout
photoreceptors. Photoreceptor expression of ClC6 is restricted to
synaptic terminals in the OPL and to vertical elements near the
OLM. These vertical elements also appear to express ClC7 and
could correspond to protein located near or within regions of the
cilium and/or the ellipsoid of the photoreceptors. The different
anatomical compartments of the vertebrate photoreceptor (outer
segment, inner segment, and presynaptic) subserve different
cellular functions (phototransduction, metabolism and gene
expression, and synaptic transmission). Perhaps the variation in
photoreceptor CLC expression is due to the specificity of different
CLC transporters for the membranes of particular organelles.
However, if that were solely the case, one would expect that ClC4
expression would be more similar to that of ClC5 because both
localize to early endosomal compartments. Yet the expression of
both ClC6 and ClC7 in vertical elements at the junction between
the outer and inner segments may support a specific role for late
endosomes and/or lysosomes at that location.
ClC5 expression in the outer limiting membrane
The outer limiting membrane is a specialized retinal structure
that serves as a semi-permeable boundary between the ONL and
photoreceptor inner segments. It is not a membrane per se, but is
composed of close appositions of the apical processes of Mu ¨ller
cells and photoreceptors. These appositions express proteins and
structures characteristic of both tight junctions and adherens
junctions and are thought to be important for maintaining retinal
structure and potentially for regulating diffusion of material into
the inner retina [51]. Though Mu ¨ller cell and ONL expression of
both ClC4 and ClC5 was pronounced, only ClC5 was expressed at
the OLM. ClC4 and ClC5 are generally targeted to similar
subcellular compartments. The presence of ClC5 (and not the
closely related ClC4) in the OLM suggests a specific role for this
transporter in OLM function.
Retinal ClC7 expression is more restricted than ClC4 and
ClC5
Our results show that ClC4 and ClC5 are fairly ubiquitously
expressed in the nuclear and plexiform layers of the retina whereas
the distribution of ClC7 is much more limited and specific.
Calretinin-positive horizontal cells express ClC4 and ClC5, but
not ClC7. In the chicken, all horizontal cells express either
calretinin or TrkA, with calretinin-expressing cells comprising the
majority [33]. We cannot rule out ClC7 expression in TrkA-
positive horizontal cells because punctate ClC7 antibody label was
present in the extreme outer portion of the INL, where horizontal
cell bodies are located.
ClC7 expression in bipolar cells was more ambiguous. PKC is
expressed by two populations of bipolar cells in the chicken retina
[36,52]. ClC4 and ClC5 were expressed in cell bodies and
projections to the OPL from both populations. ClC4 and ClC5
signal in these cells was interior to that of PKC, supporting a
cytosolic location for ClC4 and ClC5. Interestingly, though some
PKC-expressing bipolar cells appeared to also express low levels of
ClC7, the ClC7 antibody labeling co-localized with PKC on the
margins of the cell body, consistent with plasma membrane
localization. ClC7 expression is generally cytosolic, but there are
examples of plasma membrane expression in some specialized cell
types, such as osteoclasts [23].
In Mu ¨ller cells, though there was some co-labeling by the ClC7
and glutamine synthetase antibodies, we could not discern whether
this was due to close apposition of Mu ¨ller processes to ClC7
puncta in neighboring amacrine cells or to true ClC7 expression in
these retinal glial cells. Nonetheless, ClC7 signal was much less co
localized with glutamine synthetase in comparison to ClC4 and
ClC5, indicating that ClC7 expression by Mu ¨ller cells, if any, is
much less prevalent.
All CLC transporters examined were expressed in the inner
third of the INL, consistent with expression by amacrine cells.
Further examination of ClC4, 5, and 7 in double labeling
Figure 9. ClC7 is narrowly expressed in PKC-positive bipolar cells, and is absent from calretinin-positive horizontal cells. A–C, Retinal
sections double-labeled with ClC7 and calretinin antibodies show that ClC7 antibody labeling is not strong in calretinin-positive cells. Arrowheads
indicate strongly calretinin-positive amacrine cells that do not express ClC7. D–F, ClC7 is not expressed in calretinin-positive horizontal cells
(asterisks). G–I, Retinal section labeled with ClC7 and PKC antibodies reveal minimal co-localization of the two antibodies. J–L, Higher magnification,
single z plane images of a different tissue section show no co-expression of ClC7 and PKC in the OPL. M–O, Images from a single z plane from the
same z stack as in G–I. P–R, Zoomed images of the blue-bordered area in M–O show little overlap in the signals of the two antibodies, although the
asterisks indicate examples of ClC7 expression in the membrane of a PKC-positive cell. (Scale in A, 50 mm, applies to B–C, G–I, and M–O as well; Scale
D–F, 15 mm; Scale J–L, 10 mm; Scale P–R, 15 mm.)
doi:10.1371/journal.pone.0017647.g009
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(syntaxin 1) confirmed expression of those transporters by
amacrine cells. Strongly calretinin-positive amacrine cells ex-
pressed both ClC4 and ClC5, but not ClC7. The few amacrine
cells that were PKC-positive were also positive for ClC4 and
ClC5. Due to the highly punctate distribution of ClC7 antibody
label, ClC7 expression by these cells was more ambiguous. More
strikingly, ClC4 and ClC5 expression in amacrine cell bodies was
highly co-localized with that of nNOS whereas very little overlap
was seen between nNOS and ClC7. In contrast, ClC7 expression
in ChAT-positive cells was very conspicuous. ClC5 was also
expressed by cholinergic amacrine cells, but the co localization
with ChAT was less prominent. Though this investigation of CLC
transporter expression by different subtypes of amacrine cells is far
from complete, it does suggest that these proteins may be
preferentially expressed by amacrine cells that mediate different
functions, especially in the case of ClC7. ClC4 and ClC5 appeared
to be expressed in some degree by all amacrine cells whereas
ClC7, despite some admitted uncertainty caused by the highly
punctate nature of the signal, was clearly expressed in cholinergic
amacrine cells. Whether this especially strong expression is based
on an as yet un-described requirement for a greater number of
lysosomes by starburst amacrine cells or on another unknown
ClC7-mediated function is not clear at this time. However, it is
interesting to note that other Cl
2 transport proteins, NKCC and
KCC cation-Cl
2 co-transporters, have been found to be selectively
expressed in different regions of cholinergic amacrine cells, where
they actively maintain different local cytosolic Cl
2 concentrations
with important implications for cell function [53].
CLC expression in ganglion cells
The ganglion cell layer is comprised of the cell bodies of
ganglion cells and displaced amacrine cells. All CLC transporters
examined were expressed in the GCL, and there was no great
variation in their expression patterns in these cells. However, due
to the persistence of ClC5 antibody signal in the GCL after pre-
incubation with ClC5 peptide, we cannot rule out that some of the
ClC5 labeling there is nonspecific. Interestingly, only ClC5 was
strongly expressed in the NFL, and ClC5 antibody labeling there
did not overlap with that of glutamine synthetase (Fig. 7O),
suggesting that ClC5 is preferentially expressed in ganglion cell
axons.
CLC expression in the synaptic layers of the retina
ClC5 was widely expressed in the outer plexiform layer with
expression located in the processes of horizontal cells, bipolar cells,
and Mu ¨ller cells. In contrast, ClC4 and ClC7 OPL expression was
more diffuse, and individual ClC4 and ClC7 positive processes
were rarely discernable. ClC4 antibody labeling in the OPL co-
localized with PKC, but not with calretinin, suggesting that the
Figure 10. ClC7 is expressed in amacrine cells, but not widely expressed in Mu ¨ller or nNOS-positive cells. A–C, Single z plane images of
chicken retinal tissue sections double-labeled with ClC7 and HPC-1 antibodies show that ClC7 is expressed in HPC-1-positive cells. D–F, Zoom of blue
box region in A–C shows that ClC7 is expressed in amacrine cells (asterisks), particularly those with cell bodies close to the IPL. G–I, Zoom of purple
box region in A–C shows ClC7 antibody labeling in displaced amacrine cells of the ganglion cell layer (asterisk) as well as in neighboring, HPC-1
negative ganglion cells. J–L, Sections of retinal tissue double-labeled with ClC7 and GS antibodies. GS and ClC7 co-expression is limited to Mu ¨ller cell
margins in the center of the INL (arrows). M–O, Retinal sections double-labeled with ClC7 and nNOS antibodies (maximum projection images) reveal
that, except for in the GCL, ClC7 is minimally expressed in nNOS-expressing cells. (Scale A–C, 50 mm, applies to J–L and M–O as well; Scale D–F, 15 mm;
Scale G–I, 15 mm.)
doi:10.1371/journal.pone.0017647.g010
Figure 11. ClC5 and ClC7 are expressed in cholinergic cells of the chicken retina. A–C, Vertical section of chicken retinal tissue double-
labeled with ClC5 antibody and a polyclonal antibody specific for ChAT. ChAT-positive amacrine cells express ClC5 (arrows). IPL bands
immunoreactive for ChAT are also immunoreactive for ClC5 (arrowheads). D–F, Retinal tissue double-labeled with ClC7 and ChAT antibodies shows
that ClC7 expression in the INL is highly co-localized with ChAT (arrows). ClC7 is also highly expressed in the GCL and in the outermost ChAT-
immunoreactive IPL band (arrowheads). (Scale for A is 50 mm and applies for B–F as well.)
doi:10.1371/journal.pone.0017647.g011
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not in calretinin-expressing horizontal cell processes. ClC7
antibody labeling did not co-localize with either PKC or
calretinin. ClC6 was moderately expressed in the OPL. The
ClC6 signal in this layer showed a high degree of overlap with
SV2, a specific marker of photoreceptor terminals. These
observations suggest that the role of CLC transporters in signaling
in the outer retina is most likely cell-type and transporter specific.
Another key locus for CLC transporter expression diversity in
the chicken retina was the inner plexiform layer. All CLC
transporters examined, except for ClC3, showed some degree of
expression in both the ON and OFF sublamina of the IPL, and
these expression patterns are summarized in Figure 12B. All four
family members with discernable IPL expression were observed in
both the inner and the outer regions of the IPL. ClC5 was the only
CLC transporter with banding in the outermost section of the IPL
(0–15% IPL depth), whereas ClC4 and ClC7 extended horizontal
and vertical processes, respectively, and ClC6 was not expressed at
all. In the innermost section of the IPL (90–100% IPL depth), an
area thought to be particularly important for rod-driven signaling,
antibodies specific for ClC4, 5, and 6 labeled a thin, well-defined
PKC, nNOS, and calretinin immunoreactive band that was
consistently negative for ClC7. In the central IPL, the expression
of the different CLC transporters appeared to overlap to a higher
degree. However, double label experiments with different markers
revealed some subtle differences in their IPL expression patterns.
IPL bands immunoreactive for ClC4 and ClC5 antibodies were
also immunoreactive for calretinin, except at one calretinin-
positive band at the center of the IPL. In contrast, ClC4 antibody
co-localized with all PKC-positive IPL bands (but not bipolar cell
Figure 12. CLC H
+/Cl
2 antiporter expression in the chicken retina. A, Illustration of CLC transporter expression in the chicken retina. Filled
blocks represent CLC expression. Unfilled blocks indicated with dashed lines represent weak CLC antibody labeling. B, CLC transporter expression in
the inner plexiform layer.
doi:10.1371/journal.pone.0017647.g012
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PKC in the innermost immunoreactive IPL band. It is intriguing
that ClC4 and ClC5 appeared to be expressed at dendrites but not
terminals of bipolar cells, at least at the resolution level of light
microscopy. Further examination of this apparent differential
synaptic distribution at the electron microscope level would be of
interest. ClC4 and ClC5 also co-localized with nNOS in the IPL
although the overlap was less intense in the case of ClC4. ClC7
expression did not overlap with that of calretinin, PKC, or nNOS
in the IPL, but the outermost band of ClC7 antibody
immunoreactivity strongly co-localized with the outermost band
of ChAT expression. ClC5 IPL expression overlapped with both
bands of ChAT antibody labeling. Taken together, these
observations suggest that the CLCs have synapse-specific func-
tions, and it will be important to test their physiological functions
in the context of synaptic transmission.
Are CLCs differentially expressed in other tissues?
Most previous investigations of CLC transporter expression
have focused on either organ level expression or organellar
expression in various cell types. There has been comparatively
little examination of the relative expression levels of various CLC
proteins in different cell types, especially in the nervous system.
Although there is evidence that all of the Cl
2/H
+ antiporters in
the CLC protein family display similar biophysical properties and
that they are fairly broadly expressed, they have been shown to
mediate different functions. For example, knockout studies
revealed that, in the kidney, ClC5 is essential for normal
endocytosis in the proximal tubule whereas ClC7, also expressed
in the proximal tubule, is necessary for normal lysosomal protein
degradation [54]. Further, though both ClC3 and ClC7 gene
disruption results in pronounced neurodegeneration, the neuro-
degenerative process is different for the two transporters [15].
It is likely that the observed differences in CLC transporter
function stem at least in part from their different cellular addresses
[55] and this localization pattern is fairly consistent across tissues.
Little is known, however, about the functional significance of cell-
type specific expression within a tissue. Jentsch and colleagues
demonstrated a correlation between ClC5 expression and
expression of the vacuolar proton pump in different kidney cell
types [30]. Two splice variants of ClC4 are expressed in taste
receptor cells, where they are hypothesized to mediate different
functions, but are not expressed in neighboring taste-insensitive
epithelial cells [56]. In the rat vas deferens and epididymus, ClC5
is located in narrow and clear cells with strong proton pump
expression whereas ClC3 is expressed in principal cells with little
proton pump expression, and ClC4 is not expressed at all [57].
The numerous knockout and expression studies done on the CLC
Cl
2/H
+ exchangers have been extremely valuable in elucidating
the biophysical characteristics of these transporters as well as in
providing clues to their normal cellular function. The challenge
remains, however, to examine the physiological role of these
transporters in their native cellular context. The distinctive
expression patterns of CLC Cl
2/H
+ exchangers in different
retinal cell types and in the synaptic layers of the retina makes that
endeavor compelling.
Supporting Information
Figure S1 Minimal ClC3 expression in chicken retina
revealed by monoclonal antibody to ClC3 n-terminus. A,
Tissue section labeled only with secondary antibody. B, Retinal
section labeled with monoclonal ClC3 antibody reveals a low level
of labeling, if any. (Scale for A is 50 mm and applies for B as well.)
(TIF)
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